Bianca has an extensive background in both big & small biotech companies with the focus on oligonucleotide development. She worked ~4y as Formulation Scientist & Manufacturing Manager at Merck. Consequently, she decied to join Crucell for ~3y as Director CMC and helped developing vaccines for adenoviruses. Next, she joined ProQR ~7y as one of the first employees and was appointed Vice President CMC, being responsible fo the manufacturing of oligonucleotides for lung, eye and skin diseases. Finally, she worked ~1y at Frame Therapeutics as Head of Product Development. With her enormous expertise in oligonucleotides and biotech start-up dynamics, she will be supporting Hybridize as Chief Operating Officer.